{
  "docId": "019dd923-5f69-752d-a9b6-8fcc9601f794",
  "docSlug": "Kp30uSu3n5ioHQcbG5Ln",
  "documentTitle": "See the 20-slide pitch deck a psychedelics startup used to raise funds to build out a network of ketamine clinics",
  "authorId": "Pitchdecks",
  "authorName": "Novamind",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 2,
  "pageCount": 20,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "disclaimer",
  "function": "other",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b6-8fcc9601f794/2",
  "deckHref": "/decks/019dd923-5f69-752d-a9b6-8fcc9601f794",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b6-8fcc9601f794.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b6-8fcc9601f794#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.85,
        "x": 0.075,
        "y": 0.29
      },
      "kind": "disclaimer",
      "text": "This presentation (the “Presentation”) of Novamind Ventures Inc. (the “Company”) is current as of October 1, 2020, except as otherwise provided herein. It is information in a summary form and does not purport to be complete. It is not intended to be relied upon as advice to investors or potential investors and does not take into account the investment objectives, financial situation or needs of any particular investor. An investment in the Company is speculative and involves substantial risk and is only suitable for investors that are able to bear the risk of losing their entire investment. All of the information contained in this Presentation is for preliminary discussion purposes only. Final terms and conditions may change without notice and are subject to further discussion and negotiations.\n\nNo representation or warranty, express or implied, is made or given by or on behalf of the Company or any of its affiliates, directors, officers or employees as to the accuracy, completeness or fairness of the information or opinions contained in this Presentation and no responsibility or liability is accepted by any person for such information or opinions. The Company does not undertake or agree to update this Presentation or to correct any inaccuracies in, or omissions from, this Presentation that may become apparent. Persons receiving or reviewing this Presentation should not rely upon it as a complete overview of the business of the Company and should rely on their own investigation and due diligence. No person has been authorized to give any information or make any representations other than those contained in this Presentation and, if given and/or made, such information or representations must not be relied upon as having been so authorized. The contents of this Presentation are not to be construed as legal, financial or tax advice. You should consult your tax or legal advisor about the information contained in this Presentation.\n\nCertain statements in this Presentation may constitute forward-looking information within the meaning of applicable securities laws. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects,” “believes,” “anticipates,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “plans,” and variations of such words and phrases, or by statements that certain actions, events or results “may,” “will,” “could,” “would,” or “might,” “be taken,” “occur,” or “be achieved.” Certain statements, beliefs and opinions in this Presentation (including those contained in graphs, tables and charts), which reflect the Company’s or, as appropriate, the Company’s managements’ current expectations and projections about future events, constitute forward-looking information. Forward-looking information contained in this Presentation is based on certain assumptions regarding, among other things, expected growth, results of operations, performance, industry trends and growth opportunities. Forward-looking information contained in this Presentation includes, statements in respect of expected developments in the legal framework for psychedelics by the legal and regulatory authorities in Canada, anticipated revenue projections, and the expansion of businesses of the Company’s subsidiaries, Cedar Clinical Research, Inc. and Cedar Psychiatry, Inc. (the “Subsidiaries”). While revenue projections and proposed expansion are based on management’s business plans, assumptions related to the legal framework of psychedelics are based on management’s observation of general trends in society relating to the acceptance of psychedelics in therapeutic treatments, making them harder to quantify and predict than those matters that management may have control or involvement in. While management considers these assumptions to be reasonable, based on information available on the date hereof, they may prove to be incorrect.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33279416-c3e8-4559-a19d-8f83ccc603b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.085,
        "x": 0.075,
        "y": 0.238
      },
      "kind": "title",
      "text": "Disclaimer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a0e75a98-475c-4a8c-9e8b-77457119a6f3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}